Very early researchLooking for participantsNCT06329908What this trial is testingDC Combined With ICIs in the Treatment of Advanced Lung Cancer Resistant to ICIsWho this might be right forLung Cancer Zhen-Yu Ding 20
Not applicableStudy completedNCT02894775What this trial is testingFactors Influencing Inclusion in Digestive Cancer Clinical TrialsWho this might be right forDigestive Cancer Centre Hospitalier Universitaire Dijon 408
Not applicableActive Not RecruitingNCT05046821What this trial is testingSporadic Inclusion Body Myositis Natural History StudyWho this might be right forSporadic Inclusion Body MyositisInclusion Body Myositis University of California, Irvine 150
Large-scale testing (Phase 3)Study completedNCT01232894What this trial is testing12-week Open-label Evaluation of Efficacy and Safety of IndacaterolWho this might be right forChronic Obstructive Pulmonary Disease (COPD) Novartis Pharmaceuticals 90
Testing effectiveness (Phase 2)Study completedNCT01830972What this trial is testingAn Open Label Phase 2 Extension Study of Higher Dose Sialic Acid-Extended Release (SA-ER) Tablets and Sialic Acid-Immediate Release (SA-IR) Capsules in Patients With Glucosamine (UDP-N-acetyl)-2-Epimerase (GNE) MyopathyWho this might be right forGNE MyopathyHereditary Inclusion Body Myopathy (HIBM) Ultragenyx Pharmaceutical Inc 59
Large-scale testing (Phase 3)Study completedNCT00101686What this trial is testingTrial Of Irinotecan In Combination With Three Methods Of Administration Of Fluoropyrimidine.Who this might be right forColorectal Neoplasms Pfizer 547
Testing effectiveness (Phase 2)Study completedNCT00596726What this trial is testingRECOVER I Impella RECOVER LP/LD 5.0 Support System Safety and Feasibility StudyWho this might be right forCardiac Surgery Abiomed Inc. 17
Very early researchLooking for participantsNCT06891716What this trial is testing[18F]ACI-19626 PET in TDP-43 ProteinopathiesWho this might be right forFrontotemporal Dementia (FTD)Amyotrophic Lateral Sclerosis (ALS)TDP-43 Proteinopathies+2 more AC Immune SA 45
Early research (Phase 1)Study completedNCT00195637What this trial is testingIntravenous Immune Globulin to Treat Hereditary Inclusion Body MyopathyWho this might be right forHereditary Inclusion Body Myopathy National Human Genome Research Institute (NHGRI) 4
Large-scale testing (Phase 3)Ended earlyNCT02736188What this trial is testingStudy to Evaluate the Safety and Efficacy of Aceneuramic Acid Extended-Release (Ace-ER) Tablets in Patients With Glucosamine (UDP-N-acetyl)-2-epimerase Myopathy (GNEM) or Hereditary Inclusion Body Myopathy (HIBM)Who this might be right forHereditary Inclusion Body MyopathyDistal Myopathy With Rimmed VacuolesDistal Myopathy, Nonaka Type+2 more Ultragenyx Pharmaceutical Inc 143
Post-approval studies (Phase 4)Study completedNCT00851461What this trial is testingEffect of Goserelin (Zoladex®) in Spinal and Bulbar Muscular AtrophyWho this might be right forSpinobulbar Muscular AtrophyKennedy's Disease Ramathibodi Hospital 10
Not applicableActive Not RecruitingNCT07347652What this trial is testingThis Research Proposal Focuses on Evaluating the Effectiveness of a Nursing Care Protocol in Preventing Deep Vein Thrombosis (DVT) in Patients Undergoing On-pump Cardiac Surgery. The Study Will Include an Intervention Group That Receives the Nursing Protocol and a Control Group That Receives RoutineWho this might be right forOn-pump Cardiac Surgery - Prevention - Intervention - Experimental Group - Control Group - Incidence - ComplicationsDVT - Deep Vein ThrombosisDVT Prophylaxis+3 more Near East University, Turkey
Not applicableStudy completedNCT02749786What this trial is testingGenetic Basis of Rosacea Study (Control)Who this might be right forRosacea Stanford University 10
Large-scale testing (Phase 3)Active Not RecruitingNCT06768671What this trial is testingAn Open-label, Single-arm Study to Evaluate Pharmacokinetics and Safety of Subcutaneous Sonelokimab in Adolescents With Moderate to Severe Hidradenitis Suppurativa (VELA-TEEN)Who this might be right forHidradenitis Suppurativa MoonLake Immunotherapeutics AG 35
Not applicableStudy completedNCT04823143What this trial is testingNatural History Study of Patients With VCP-related DiseaseWho this might be right forIBMPFD Nationwide Children's Hospital 44
Testing effectiveness (Phase 2)Active Not RecruitingNCT05139602What this trial is testingAssess Disease Activity and Safety of Subcutaneous Lutikizumab (ABT-981) in Adult Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-Tumor Necrosis Factor (TNF) Therapy and Who Are Naïve to Biologic TherapyWho this might be right forHidradenitis Suppurativa AbbVie 210
Not applicableStudy completedNCT06644482What this trial is testingExercise as Treatment for Patients With Inclusion Body MyositisWho this might be right forInclusion Body Myositis (IBM)Feasibility Study Oslo University Hospital 15
Testing effectiveness (Phase 2)Study completedNCT01423110What this trial is testingEfficacy, Safety and Tolerability of BYM338 in Patients With Sporadic Inclusion Body MyositisWho this might be right forSporadic Inclusion Body Myositis Novartis Pharmaceuticals 14
Large-scale testing (Phase 3)Study completedNCT02250443What this trial is testingStudy of Long-term Safety, Efficacy Tolerability of BYM338 in Patients With Sporadic Inclusion Body MyositisWho this might be right forSporadic Inclusion Body Myositis (sIBM) Novartis Pharmaceuticals 10
Large-scale testing (Phase 3)Ended earlyNCT00295776What this trial is testingLamictal in the Treatment of Post-Herpetic NeuralgiaWho this might be right forNeuralgia, Postherpetic George Washington University